Evaluation of Humoral and Cell-Mediated Immunity Induced by Quadrivalent Influenza Vaccine in Pre-COVID-19 Japan
Viruses · 2025
DOI: 10.3390/v17050626 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Naruhito Otani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control and Prevention, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan. Hauptthemen laut MEDLINE: Immunity, Cellular, Influenza Vaccines, Immunity, Humoral, Influenza, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hyogo Medical University Grant for Research Promotion, Hyogo Medical University Grant for Research Promotion, 2023, Japan Society for the Promotion of Science (KAKENHI).
Abstract (Originalsprache)
This study aimed to evaluate the humoral and cell-mediated immune responses induced by an inactivated influenza vaccine (IIV4) during the 2019/2020 influenza season in Japan. We collected blood samples from 25 healthy adults before vaccination, 2 weeks post-vaccination, and 5 months post-vaccination. Humoral and cell-mediated immunities were assessed based on hemagglutination inhibition antibody titers and interferon-γ (IFN-γ) levels, respectively. The geometric mean titer ratio for A/H3N2 exceeded 2.5, meeting the criteria outlined by the European Medicines Agency guidelines; other strains did not achieve similar thresholds. IFN-γ responses indicated significant activation for all strains, with 32–36% of participants exhibiting ≥ 1.5-fold increases. Due to the implementation of infection control measures against COVID-19, influenza activity was not observed during the 2020/2021 and 2021/2022 seasons, potentially altering influenza immunity. Our findings highlight the importance of both humoral and cell-mediated immunity in evaluating vaccine immunogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection Control and Prevention, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan.
- Department of Public Health, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan.
- Department of Microbiology, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan.
- Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan.
ORCID-Profile: Kaori Ishikawa, Takashi Ueda
Förderung
- Hyogo Medical University Grant for Research Promotion
- Hyogo Medical University Grant for Research Promotion, 2023
- Japan Society for the Promotion of Science (KAKENHI)
Zitieren
APA
Otani, N., Okuno, T., Yamada, K., Tsuchida, T., Ishikawa, K., Ichiki, K., Ueda, T., Takesue, Y., Higasa, S., & Nakajima, K. (2025). Evaluation of Humoral and Cell-Mediated Immunity Induced by Quadrivalent Influenza Vaccine in Pre-COVID-19 Japan. Viruses. https://doi.org/10.3390/v17050626
Vancouver
Otani N, Okuno T, Yamada K, Tsuchida T, Ishikawa K, Ichiki K, et al. Evaluation of Humoral and Cell-Mediated Immunity Induced by Quadrivalent Influenza Vaccine in Pre-COVID-19 Japan. Viruses. 2025. doi:10.3390/v17050626
BibTeX
@article{Otani2025,
author = {Otani, Naruhito and Okuno, Toshiomi and Yamada, Kumiko and Tsuchida, Toshie and Ishikawa, Kaori and Ichiki, Kaoru and Ueda, Takashi and Takesue, Yoshio and Higasa, Satoshi and Nakajima, Kazuhiko},
title = {Evaluation of Humoral and Cell-Mediated Immunity Induced by Quadrivalent Influenza Vaccine in Pre-COVID-19 Japan},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050626}
}
EUVIMED